| Serial Number | 98667079 |
| Word Mark | AUTO-T |
| Filing Date | Thursday, July 25, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, July 15, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 15, 2025 |
| Goods and Services | Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology; providing technical information about biomanufacturing and manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins |
| Pseudo Mark | AUTO T |
| Goods and Services | Research and development, and consulting services related thereto in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; genetic engineering services; biotechnology research and development; scientific, pharmaceutical, and medical research services relating to biological treatment and bioproduction; design and development of technology platforms, namely, biomanufacturing relating to biological treatment for use in the manufacture of pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; provision of information relating to research and development of biopharmaceuticals that are manufactured using biological treatment and bioproduction platforms; development of new technology for others in the field of biotechnology, biomanufacturing, and pharmaceuticals; new product design services; biotechnology design services in the nature of development of new technology for others in the field of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; design and development of biomanufacturing platforms for others, namely, product development for manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 25, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 25, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | National Resilience, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | National Resilience, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Event Date | Event Description |
| Wednesday, February 12, 2025 | ASSIGNED TO EXAMINER |
| Thursday, July 25, 2024 | NEW APPLICATION ENTERED |
| Tuesday, February 11, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 19, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 19, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 4, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, March 4, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 19, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 4, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, May 14, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 13, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, June 13, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Friday, June 13, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, June 13, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 9, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 15, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 15, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, June 13, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, May 14, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |